The durability of porcine xenograft valves and conduits in children

D. C. Miller, E. B. Stinson, P. E. Oyer, M. E. Billingham, P. T. Pitlick, B. A. Reitz, S. W. Jamieson, William A Baumgartner, N. E. Shumway

Research output: Contribution to journalArticle

Abstract

One hundred four patients younger than 20 years of age underwent intracardiac xenograft valve replacement (n = 41) or extracardiac conduit implantation (n = 63). Long-term follow-up averaged 4.5 and 4.3 years, respectively, and cumulative follow-up totaled 344 patient-years (pt-yr). Thirty patients were followed more than 5 years. Functional results and survival were satisfactory, but valve failure and conduit failure prompted 23 reoperations at linearized rates of 10.1 ± 2.6% and 4.1 ± 1.5%/pt-yr, respectively. The rate of valve failure due to leaflet fibrocalcification (primary tissue failure [PTF]) was 8.1 ± 2.4%/pt-yr. Among patients who underwent valve replacement, 52 ± 13% were free of reoperation at 5 years (59 ± 13% for PTF only), as were 80 ± 9% of patients who received an extracardiac conduit. There were no deaths associated with the 22 late reoperations or with the 21 reoperations for PTF. Valve failure was due to PTF in 80% of cases; conversely, isolated valvular PTF was the cause of conduit failure in only one of eight patients. The most common cause of conduit failure was exuberant pseudointimal proliferation in the proximal conduit, which was seen in six of eight patients (75%) with or without other sites of obstruction and responsible for nine of the 15 obstructions (60%). These results prompt consideration of alternative nonconduit techniques where possible, and reemphasize the clinical need for superior valve substitutes and biomaterials for use in the pediatric age group.

Original languageEnglish (US)
JournalCirculation
Volume66
Issue number2 II
StatePublished - 1982
Externally publishedYes

Fingerprint

Heterografts
Swine
Reoperation
Biocompatible Materials
Age Groups
Pediatrics
Survival

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Miller, D. C., Stinson, E. B., Oyer, P. E., Billingham, M. E., Pitlick, P. T., Reitz, B. A., ... Shumway, N. E. (1982). The durability of porcine xenograft valves and conduits in children. Circulation, 66(2 II).

The durability of porcine xenograft valves and conduits in children. / Miller, D. C.; Stinson, E. B.; Oyer, P. E.; Billingham, M. E.; Pitlick, P. T.; Reitz, B. A.; Jamieson, S. W.; Baumgartner, William A; Shumway, N. E.

In: Circulation, Vol. 66, No. 2 II, 1982.

Research output: Contribution to journalArticle

Miller, DC, Stinson, EB, Oyer, PE, Billingham, ME, Pitlick, PT, Reitz, BA, Jamieson, SW, Baumgartner, WA & Shumway, NE 1982, 'The durability of porcine xenograft valves and conduits in children', Circulation, vol. 66, no. 2 II.
Miller DC, Stinson EB, Oyer PE, Billingham ME, Pitlick PT, Reitz BA et al. The durability of porcine xenograft valves and conduits in children. Circulation. 1982;66(2 II).
Miller, D. C. ; Stinson, E. B. ; Oyer, P. E. ; Billingham, M. E. ; Pitlick, P. T. ; Reitz, B. A. ; Jamieson, S. W. ; Baumgartner, William A ; Shumway, N. E. / The durability of porcine xenograft valves and conduits in children. In: Circulation. 1982 ; Vol. 66, No. 2 II.
@article{c1f6e24a9ebc41eebb853cfe499c4e72,
title = "The durability of porcine xenograft valves and conduits in children",
abstract = "One hundred four patients younger than 20 years of age underwent intracardiac xenograft valve replacement (n = 41) or extracardiac conduit implantation (n = 63). Long-term follow-up averaged 4.5 and 4.3 years, respectively, and cumulative follow-up totaled 344 patient-years (pt-yr). Thirty patients were followed more than 5 years. Functional results and survival were satisfactory, but valve failure and conduit failure prompted 23 reoperations at linearized rates of 10.1 ± 2.6{\%} and 4.1 ± 1.5{\%}/pt-yr, respectively. The rate of valve failure due to leaflet fibrocalcification (primary tissue failure [PTF]) was 8.1 ± 2.4{\%}/pt-yr. Among patients who underwent valve replacement, 52 ± 13{\%} were free of reoperation at 5 years (59 ± 13{\%} for PTF only), as were 80 ± 9{\%} of patients who received an extracardiac conduit. There were no deaths associated with the 22 late reoperations or with the 21 reoperations for PTF. Valve failure was due to PTF in 80{\%} of cases; conversely, isolated valvular PTF was the cause of conduit failure in only one of eight patients. The most common cause of conduit failure was exuberant pseudointimal proliferation in the proximal conduit, which was seen in six of eight patients (75{\%}) with or without other sites of obstruction and responsible for nine of the 15 obstructions (60{\%}). These results prompt consideration of alternative nonconduit techniques where possible, and reemphasize the clinical need for superior valve substitutes and biomaterials for use in the pediatric age group.",
author = "Miller, {D. C.} and Stinson, {E. B.} and Oyer, {P. E.} and Billingham, {M. E.} and Pitlick, {P. T.} and Reitz, {B. A.} and Jamieson, {S. W.} and Baumgartner, {William A} and Shumway, {N. E.}",
year = "1982",
language = "English (US)",
volume = "66",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2 II",

}

TY - JOUR

T1 - The durability of porcine xenograft valves and conduits in children

AU - Miller, D. C.

AU - Stinson, E. B.

AU - Oyer, P. E.

AU - Billingham, M. E.

AU - Pitlick, P. T.

AU - Reitz, B. A.

AU - Jamieson, S. W.

AU - Baumgartner, William A

AU - Shumway, N. E.

PY - 1982

Y1 - 1982

N2 - One hundred four patients younger than 20 years of age underwent intracardiac xenograft valve replacement (n = 41) or extracardiac conduit implantation (n = 63). Long-term follow-up averaged 4.5 and 4.3 years, respectively, and cumulative follow-up totaled 344 patient-years (pt-yr). Thirty patients were followed more than 5 years. Functional results and survival were satisfactory, but valve failure and conduit failure prompted 23 reoperations at linearized rates of 10.1 ± 2.6% and 4.1 ± 1.5%/pt-yr, respectively. The rate of valve failure due to leaflet fibrocalcification (primary tissue failure [PTF]) was 8.1 ± 2.4%/pt-yr. Among patients who underwent valve replacement, 52 ± 13% were free of reoperation at 5 years (59 ± 13% for PTF only), as were 80 ± 9% of patients who received an extracardiac conduit. There were no deaths associated with the 22 late reoperations or with the 21 reoperations for PTF. Valve failure was due to PTF in 80% of cases; conversely, isolated valvular PTF was the cause of conduit failure in only one of eight patients. The most common cause of conduit failure was exuberant pseudointimal proliferation in the proximal conduit, which was seen in six of eight patients (75%) with or without other sites of obstruction and responsible for nine of the 15 obstructions (60%). These results prompt consideration of alternative nonconduit techniques where possible, and reemphasize the clinical need for superior valve substitutes and biomaterials for use in the pediatric age group.

AB - One hundred four patients younger than 20 years of age underwent intracardiac xenograft valve replacement (n = 41) or extracardiac conduit implantation (n = 63). Long-term follow-up averaged 4.5 and 4.3 years, respectively, and cumulative follow-up totaled 344 patient-years (pt-yr). Thirty patients were followed more than 5 years. Functional results and survival were satisfactory, but valve failure and conduit failure prompted 23 reoperations at linearized rates of 10.1 ± 2.6% and 4.1 ± 1.5%/pt-yr, respectively. The rate of valve failure due to leaflet fibrocalcification (primary tissue failure [PTF]) was 8.1 ± 2.4%/pt-yr. Among patients who underwent valve replacement, 52 ± 13% were free of reoperation at 5 years (59 ± 13% for PTF only), as were 80 ± 9% of patients who received an extracardiac conduit. There were no deaths associated with the 22 late reoperations or with the 21 reoperations for PTF. Valve failure was due to PTF in 80% of cases; conversely, isolated valvular PTF was the cause of conduit failure in only one of eight patients. The most common cause of conduit failure was exuberant pseudointimal proliferation in the proximal conduit, which was seen in six of eight patients (75%) with or without other sites of obstruction and responsible for nine of the 15 obstructions (60%). These results prompt consideration of alternative nonconduit techniques where possible, and reemphasize the clinical need for superior valve substitutes and biomaterials for use in the pediatric age group.

UR - http://www.scopus.com/inward/record.url?scp=0019973309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019973309&partnerID=8YFLogxK

M3 - Article

C2 - 7083540

AN - SCOPUS:0019973309

VL - 66

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2 II

ER -